Home » Authors » Holland Johnson

Articles by Holland Johnson

Rising costs, regulatory quagmire make medical future uncertain

Dec. 1, 2004

By Holland Johnson

Cardio innovation in the clinical setting is explored at conference

Dec. 1, 2004

By Holland Johnson

Vitex Stock Falls On Enrollment Suspension In Inactine Phase III

Nov. 29, 2004

By Holland Johnson

Vitex Stock Falls On Enrollment Suspension In Inactine Phase III

Nov. 29, 2004

By Holland Johnson

GE Healthcare calls its Vivid i 'the virtual stethoscope of future'

Oct. 1, 2004

By Holland Johnson

Abbott enrolls first patient in study of its ZoMaxx DES

Oct. 1, 2004

By Holland Johnson

ReValving may change valve replacement and open-heart surgery

Aug. 1, 2004

By Holland Johnson

St. Jude becomes third company with entry in U.S. CRT-D market

Aug. 1, 2004

By Holland Johnson

Medtronic, Genzyme form j-v for cardio disease therapies

July 1, 2004

By Holland Johnson

Two firms' cardiac diagnostic tests are cleared for sale by FDA

June 1, 2004

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...